Sysmex Corporation：市場シェア分析...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Healthcare IT 12
3.1.1 Clinical IT Systems 12
3.2 In Vitro Diagnostics 13
3.2.1 Clinical Chemistry 13
3.2.2 Haematology 13
3.2.3 Histology And Cytology 13
4 Company Snapshot 14
4.1 Key Facts 14
4.2 Company Overview 14
4.3 Financial Performance 14
4.4 SWOT Snapshot 14
4.5 Business Overview 14
4.6 Major Products and Services 16
4.6.1 Overview 16
5 History 17
6 SWOT Analysis 23
6.1 Overview 23
6.2 Sysmex Corporation Strengths 23
6.2.1 Improving Liquidity Reserves 23
6.2.2 Strong Research and Development Activities 23
6.2.3 Diversified Geographic Presence 24
6.3 Sysmex Corporation Weaknesses 24
6.3.1 Poor Resource Management 24
6.3.2 Low Debt to Equity Ratio 24
6.3.3 High Selling, General and Administrative Expenses 25
6.4 Sysmex Corporation Opportunities 25
6.4.1 Strategic Collaborations and Acquisitions 25
6.4.2 Growing In Vitro Diagnostics Market 25
6.4.3 New Product Launches 26
6.5 Sysmex Corporation Threats 26
6.5.1 Changing Diagnostic Market Conditions 26
6.5.2 Currency Fluctuations 26
6.5.3 Procurement of Raw Materials 26
6.5.4 Increasing Competition 26
7 Competitors 28
8 Competitive Landscape 29
8.1 In Vitro Diagnostics (Clinical Chemistry), Global, Market Share (%), 2011 29
8.2 Sysmex Corporation, In Vitro Diagnostics (Clinical Chemistry), by Region, Market Share (2011) 30
8.3 Sysmex Corporation, In Vitro Diagnostics (Clinical Chemistry), by Country, Market Share (2011) 31
8.4 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 33
8.5 Sysmex Corporation, In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 35
8.6 Sysmex Corporation, In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 36
8.7 In Vitro Diagnostics (Histology And Cytology), Global, Market Share (%), 2011 38
8.8 Sysmex Corporation, In Vitro Diagnostics (Histology And Cytology), by Region, Market Share (2011) 39
8.9 Sysmex Corporation, In Vitro Diagnostics (Histology And Cytology), by Country, Market Share (2011) 40
8.10 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 42
9 Sysmex Corporation Medical Equipment Market Share Analysis by Category 45
9.1 Sysmex Corporation, Global, Category Revenue Share (2011) 45
9.2 Sysmex Corporation, Asia-Pacific, Category Revenue Share (2011) 47
9.2.1 Sysmex Corporation, Australia, Category Revenue Share (2011) 49
9.2.2 Sysmex Corporation, China, Category Revenue Share (2011) 51
9.2.3 Sysmex Corporation, India, Category Revenue Share (2011) 53
9.2.4 Sysmex Corporation, Japan, Category Revenue Share (2011) 55
9.2.5 Sysmex Corporation, Other Asia-Pacific, Category Revenue Share (2011) 57
9.3 Sysmex Corporation, Europe, Category Revenue Share (2011) 59
9.3.1 Sysmex Corporation, France, Category Revenue Share (2011) 61
9.3.2 Sysmex Corporation, Germany, Category Revenue Share (2011) 63
9.3.3 Sysmex Corporation, Italy, Category Revenue Share (2011) 65
9.3.4 Sysmex Corporation, Spain, Category Revenue Share (2011) 67
9.3.5 Sysmex Corporation, United Kingdom, Category Revenue Share (2011) 69
9.3.6 Sysmex Corporation, Other Europe, Category Revenue Share (2011) 71
9.4 Sysmex Corporation, Middle East and Africa, Category Revenue Share (2011) 73
9.5 Sysmex Corporation, North America, Category Revenue Share (2011) 75
9.5.1 Sysmex Corporation, Canada, Category Revenue Share (2011) 77
9.5.2 Sysmex Corporation, United States, Category Revenue Share (2011) 79
9.6 Sysmex Corporation, South and Central America, Category Revenue Share (2011) 81
9.6.1 Sysmex Corporation, Brazil, Category Revenue Share (2011) 83
9.6.2 Sysmex Corporation, Mexico, Category Revenue Share (2011) 85
9.6.3 Sysmex Corporation, Other South and Central America, Category Revenue Share (2011) 87
10 Key Employees 89
11 Key Employee Biographies 90
12 Company Statement 91
13 Locations And Subsidiaries 92
13.1 Head Office 92
13.2 Other Locations & Subsidiaries 92
14 Financial Deals Landscape 94
14.1 Sysmex Corporation, Deals Volume Summary, 2007 to YTD 2013 94
15 Sysmex Corporation Detailed Deal Summary 96
15.1 Partnerships 96
15.1.1 Epigenomics Enters Into Licensing Agreement With Sysmex 96
15.1.2 Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 97
15.1.3 Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 98
15.1.4 Sysmex Extends Distribution Agreement With Roche 99
15.1.5 IPSOGEN Enters Into Distribution Agreement With Sysmex 100
15.1.6 Sysmex Enters Into Co-Development Agreement With ARKRAY 101
15.1.7 Sysmex Enters Into Distribution Agreement With Malvern Instruments 102
15.1.8 Sysmex America Enters Into Exclusive Distribution Agreement With Medica 103
15.1.9 Siemens Healthcare Diagnostics Enters Into Agreement With Sysmex America 104
15.1.10 Sysmex Europe Enters Into An Agreement with AdnaGen 105
15.1.11 Sysmex Enters Into Joint Venture Agreement With Transasia Bio-Medicals 106
15.1.12 Sysmex Forms Joint Venture With bioMerieux 107
15.1.13 Siemens Medical Extends Its Distribution Agreement With Sysmex America 108
15.1.14 Sysmex America Enters Into Co-Marketing Agreement With Bio-Rad Labs 109
15.1.15 Sysmex Corporation Enters Into An Agreement With Biomerieux 110
15.1.16 Sysmex Extends Distribution Agreement With Roche 111
15.1.17 Sysmex Enters Into Co-Marketing Agreement With Roche 112
15.2 Asset Transactions 113
15.2.1 Vision4health Acquires Molis Information System From Sysmex 113
15.3 Acquisition 114
15.3.1 Sysmex Acquires Stake In Sysmex Taiwan, Medical Device Company 114
15.3.2 Sysmex Acquires Goffin Meyvis Analytical & Medical Systems 115
15.3.3 Sysmex Acquires Remaining 25% Stake In Sysmex India, Lab Regents And Instruments Manufacturer 116
15.3.4 Sysmex Acquires Remaining 25% Stake In Sysmex Transasia Bio-Medicals 117
15.3.5 Sysmex Acquires Remaining 49.2% Stake In CNA, Healthcare IT Company 118
16 Recent Developments 119
16.1 Strategy And Business Planning 119
16.1.1 May 10, 2011: Sysmex Announces New Group Mid-Term Management Plan 119
16.1.2 Apr 28, 2011: Sysmex Establishes Subsidiary In Philippines 119
16.1.3 Apr 19, 2011: Sysmex Establishes Subsidiary In Russia 119
16.1.4 Jan 13, 2010: Sysmex Announces Establishment Of Overseas Subsidiary In Spain To Expand Life Science Business 120
16.1.5 Nov 18, 2008: Sysmex Establishes New Affiliate In Dubai 120
16.2 Financial Announcements 121
16.2.1 Feb 05, 2013: Sysmex Reports Revenue Of JPY101.4 Billion For Nine Months Ended December 31, 2012 121
16.2.2 Nov 06, 2012: Sysmex Reports Revenue Of JPY67.2 Billion In H1 Fiscal 2013 122
16.2.3 Aug 02, 2012: Sysmex Reports Revenue Of JPY31.7 Billion In Q1 Fiscal 2013 123
16.2.4 May 09, 2012: Sysmex Reports Revenue Of JPY134.7 Billion In Fiscal 2012 123
16.2.5 Feb 03, 2012: Sysmex Reports Revenue Of JPY96.9 Billion For Nine Months Ended December 31, 2011 124
16.2.6 Nov 07, 2011: Sysmex Reports Revenues Of JPY65.3 Billion In H1 Fiscal 2012 124
16.2.7 Aug 03, 2011: Sysmex Reports Revenues Of JPY30.8 Billion In Q1 Fiscal 2012 125
16.2.8 May 10, 2011: Sysmex Reports Revenues Of JPY124.7 Billion In Fiscal 2011 126
16.2.9 Feb 02, 2011: Sysmex Reports Revenues Of JPY89.7 Billion In Nine Months Ended December 31, 2010 126
16.2.10 Nov 05, 2009: Sysmex Reports Net Income Of JPY4.3 Billion In H1 Fiscal 2010 126
16.2.11 Aug 04, 2009: Sysmex Posts Net Income Of JPY1.1 Billion In Q1 Fiscal 2010 128
16.2.12 May 11, 2009: Sysmex Posts Net Sales Of JPY111.8 Billion For Fiscal 2009 129
16.2.13 Feb 03, 2009: Sysmex Reports Net Income Of JPY4.6 Billion For Nine Months Of Fiscal 2009 130
16.2.14 Nov 05, 2008: Sysmex Reports 1H Fiscal 2009 Results 131
16.2.15 Aug 04, 2008: Sysmex Reports 1Q Fiscal 2009 Results 132
16.2.16 May 08, 2008: Sysmex Reports Fiscal 2008 Results 134
16.2.17 Feb 05, 2008: Sysmex Reports Nine Months Fiscal 2008 Results 135
16.2.18 Nov 08, 2007: Sysmex Reports 1H Fiscal 2007 Results 137
16.2.19 Aug 03, 2007: Sysmex Reports Q1 Fiscal 2007 Results 137
16.2.20 May 10, 2007: Sysmex Reports Fiscal 2006 Results 137
16.2.21 Aug 03, 2006: Sysmex Reports Q1 Fiscal 2006 Results 138
16.3 Corporate Communications 139
16.3.1 May 11, 2009: Sysmex Announce Management Changes 139
16.3.2 Mar 05, 2009: Sysmex Corporation Announces Executive Changes 140
16.3.3 Sep 29, 2008: Sysmex Director Retires 140
16.3.4 Sep 12, 2008: Sysmex Announces Management Appointments 140
16.4 Product News 141
16.4.1 Dec 25, 2012: Sysmex Launches HISCL-5000, New-Model Automated Immunoassay System For Immunochemistry Testing 141
16.4.2 Jul 22, 2011: Sysmex Launches Automated Blood Coagulation Analyzer CS-5100 141
16.4.3 Jan 17, 2005: Sysmex Develops Technology To Diagnose The Risk Of Post-Operative Recurrence Of Early-Stage Cancer 142
16.5 Other Significant Developments 142
16.5.1 Mar 09, 2012: Sysmex Announces Organizational Changes 142
16.5.2 Mar 24, 2009: Sysmex And Siemens Renew Global Agreement 143
16.5.3 Jun 15, 2007: Sysmex Extends Distribution Agreement With Roche 143
17 Appendix 144
17.1 Research Methodology 145
17.2 Secondary Research 145
17.3 Primary Research 145
17.4 Models 146
17.5 Forecasts 146
17.6 Expert Panels 146
17.7 GlobalData Consulting 146
17.8 Currency Conversion 147
17.9 Contact Us 148
17.10 Disclaimer 148